These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33646310)

  • 1. Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic.
    Janiaud P; Axfors C; Ioannidis JPA; Hemkens LG
    JAMA Netw Open; 2021 Mar; 4(3):e210330. PubMed ID: 33646310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial.
    Knowlson C; Torgerson DJ
    F1000Res; 2020; 9():1017. PubMed ID: 33447376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter Survey.
    Samsky MD; DeVore AD; McIlvennan CK; Granger CB; Granger BB; Hernandez AF; Felker GM; Fonarow GC; Albert NM; Piña IL; Lanfear D; Allen LA
    Circ Heart Fail; 2020 Sep; 13(9):e007456. PubMed ID: 32700547
    [No Abstract]   [Full Text] [Related]  

  • 4. Preserving Clinical Trial Integrity During the Coronavirus Pandemic.
    McDermott MM; Newman AB
    JAMA; 2020 Jun; 323(21):2135-2136. PubMed ID: 32211830
    [No Abstract]   [Full Text] [Related]  

  • 5. Trials in pandemics: here we go again?
    Harris S; Palmer E; Fong K
    Br J Anaesth; 2021 Jan; 126(1):e42-e44. PubMed ID: 33138966
    [No Abstract]   [Full Text] [Related]  

  • 6. The COVID-19 pandemic: is our medicine still evidence-based?
    Deana C
    Ir J Med Sci; 2021 Feb; 190(1):11-12. PubMed ID: 32468413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19.
    Ramanan M; Tong SYC; Kumar A; Venkatesh B
    JAMA Netw Open; 2022 Feb; 5(2):e220444. PubMed ID: 35212752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for Early COVID-19: A Critical Need.
    Kim PS; Read SW; Fauci AS
    JAMA; 2020 Dec; 324(21):2149-2150. PubMed ID: 33175121
    [No Abstract]   [Full Text] [Related]  

  • 9. ECMO during the COVID-19 pandemic: When is it justified?
    Heinsar S; Peek GJ; Fraser JF
    Crit Care; 2020 Nov; 24(1):650. PubMed ID: 33213485
    [No Abstract]   [Full Text] [Related]  

  • 10. Increase in recruitment upon integration of trial into a clinical care pathway: an observational study.
    Yip KP; Gompertz S; Snelson C; Willson J; Madathil S; Huq SS; Rauf F; Salmon N; Tengende J; Tracey J; Cooper B; Filby K; Ball S; Parekh D; Dosanjh DPS
    BMJ Open Respir Res; 2021 Jul; 8(1):. PubMed ID: 34230034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings.
    Narayanan S; Chua JV; Heil E
    J Gen Intern Med; 2020 Nov; 35(11):3359-3360. PubMed ID: 32885370
    [No Abstract]   [Full Text] [Related]  

  • 12. The resilience of two professionalized departmental health insurance units during the COVID-19 pandemic in Senegal.
    Mbow NB; Senghor I; Ridde V
    J Glob Health; 2020 Dec; 10(2):020394. PubMed ID: 33214897
    [No Abstract]   [Full Text] [Related]  

  • 13. Tracheotomy Outcomes in 64 Ventilated COVID-19 Patients at a High-Volume Center in Bronx, NY.
    Ahmed Y; Cao A; Thal A; Shah S; Kinkhabwala C; Liao D; Li D; Parides M; Mehta V; Ow T; Smith R; Schiff BA
    Laryngoscope; 2021 Jun; 131(6):E1797-E1804. PubMed ID: 33410517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promise and pitfalls of composite endpoints in sepsis and COVID-19 clinical trials.
    Brown PM; Rogne T; Solligård E
    Pharm Stat; 2021 Mar; 20(2):413-417. PubMed ID: 32893957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan Medicine.
    Spector-Bagdady K; Higgins PDR; Aaronson KD; Birk J; Flaherty KR; Gregg KS; Hyzy RC; Kaul DR; Lauring AS; Magee JC; Meurer WJ; Park PK; Scott P; Lok AS
    Clin Infect Dis; 2020 Nov; 71(16):2187-2190. PubMed ID: 32392334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond.
    Sethi S; Kumar A; Mandal A; Shaikh M; Hall CA; Kirk JMW; Moss P; Brookes MJ; Basu S
    Trials; 2021 Apr; 22(1):296. PubMed ID: 33879208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A literature review of consent declines and consent withdrawals in randomized controlled trials conducted during the COVID-19 pandemic.
    Gogtay NJ; Sheth HJ; Maurya MR; Belhekar MN; Thatte UM
    J Postgrad Med; 2021; 67(3):134-138. PubMed ID: 34414930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of COVID-19 on clinical research for Neglected Tropical Diseases (NTDs): A case study of bubonic plague.
    Rasoanaivo TF; Bourner J; Randriamparany RN; Gamana TM; Andrianaivoarimanana V; Raherivelo MH; Randriamampionona H; Rajerison M; Raberahona M; Salam AP; Edwards T; Olliaro PL; Randremanana RV
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0010064. PubMed ID: 34928955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators to patient recruitment to a cluster randomized controlled trial in primary care: lessons for future trials.
    Foster JM; Sawyer SM; Smith L; Reddel HK; Usherwood T
    BMC Med Res Methodol; 2015 Mar; 15():18. PubMed ID: 25887970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry.
    Batta A; Khirasaria R; Kapoor V; Varshney D
    J Basic Clin Physiol Pharmacol; 2020 Dec; 32(3):267-278. PubMed ID: 33578506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.